Ophthalmic pharmaceutical companies scheduled to present at upcoming investor conferences
Ocular Therapeutic, Rezolute, and Opthea will all present at the H.C. Wainwright 25th Annual Global Investment Conference being held in New York City in September.
Ocular Therapeutic, Rezolute, and Opthea will all present at the H.C. Wainwright 25th Annual Global Investment Conference being held in New York City in September. (Image Credit: ©kasto - Adobe.Stock.com)
Ophthalmic pharmaceutical companies are slated to participate in upcoming investors conferences. These conferences will highlight the current state of the companies and showcase their pipelines as each one works towards new solutions for some of the industry’s leading causes of blindness and vision loss.
H.C. Wainwright 25th Annual Global Investment Conference
The H.C. Wainwright 25th Annual Global Investment Conference will be held at the Lotte New York Palace Hotel in New York City from September 11-13, 2023.
On September 12, 2023, Ocular Therapeutix will be hosting one-on-one meetings with investors at this conference. The company is focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye.1
Also on September 12, 2023, Rezolute will have a company presentation by Nevan Charles Elam, Chief Executive Officer and Founder, at 2:00 pm ET. Rezolute is currently developing RZ402, an orally available plasma kallikrein inhibitor, for the treatment of diabetic macular edema. A replay will be archived for 90 days on the company’s website following the presentation date.2
Opthea Limited has also announced that Tim Morris, the company’s Chief Financial Officer will present at the conference. Morris will present on Wednesday, September 13 at 12:00 pm ET. The presentation will available to access live by registering online. An archive of the presentation may be accessed for 90 days on the Investors page of the Opthea website at https://ir.opthea.com/. Opthea’s lead product candidate OPT-302 is in pivotal Phase 3 clinical trials and being developed for use in combination with anti-VEGF-A monotherapies to achieve broader inhibition of the VEGF family.3
Cantor Global Healthcare Conference 2023
Cantor Fitzgerald Global Healthcare Conference will place September 26-28, 2023 at the Intercontinental New York Barclay in New York City.
Ocular Therapeutix is scheduled to hold a Fireside Chat on Wednesday, September 27, 2023 at 3:00 pm ET for as a part of the conference.1
Rezolute will host a panel presentation on Tuesday, September 26, 2023 at 2:10 pm ET at this event.2
References:
Ocular Therapeutix™ to Present at Three Upcoming Investor Conferences. September 6, 2023. Accessed September 7, 2023.https://investors.ocutx.com/news-releases/news-release-details/ocular-therapeutixtm-present-three-upcoming-investor-2
Rezolute to Participate in Upcoming Investor Conferences in September. September 6, 2023. Accessed September 7, 2023. https://www.globenewswire.com/news-release/2023/09/06/2738189/0/en/Rezolute-to-Participate-in-Upcoming-Investor-Conferences-in-September.html
Opthea to Present at the H.C. Wainwright 25th Annual Global Investment Conference. September 6, 2023. Accessed September 7, 2023. https://www.globenewswire.com/news-release/2023/09/07/2739067/0/en/Opthea-to-Present-at-the-H-C-Wainwright-25th-Annual-Global-Investment-Conference.html
